Monte Rosa Therapeutics (GLUE) Stock Chart & Stock Price History $5.04 +0.32 (+6.66%) Closing price 07/3/2025 03:46 PM EasternExtended Trading$5.00 -0.05 (-0.99%) As of 07/3/2025 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Monte Rosa Therapeutics Stock Price Performance The Monte Rosa Therapeutics (GLUE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 38.60%, with a year-to-date return of -27.31%. In the past month, the stock has increased 9.20%, reflecting recent market activity. As of the latest close, Monte Rosa Therapeutics traded at $5.05 with a market cap of $310.32 million and volume of 198,928 shares. Receive GLUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+11.86%1 Month Performance+9.20%3 Month Performance+27.72%Year-To-Date Performance-27.31%1 Year Performance+38.60% GLUE Stock Chart for Saturday, July, 5, 2025 GLUE Chart by TradingView Monte Rosa Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$5.05$5.05$4.88$4.64198,928 shs$310.32 million07/03/2025$4.73$5.05+6.66%$4.88$4.64198,928 shs$310.32 million07/02/2025$4.61$4.73+2.60%$4.84$4.59298,476 shs$290.94 million07/01/2025$4.51$4.61+2.22%$4.66$4.42343,798 shs$283.56 million06/30/2025$4.60$4.51-1.96%$4.70$4.50368,778 shs$277.41 million06/27/2025$4.66$4.60-1.29%$4.71$4.52942,428 shs$282.95 million06/26/2025$4.77$4.66-2.31%$4.77$4.59317,903 shs$286.64 million06/25/2025$4.74$4.77+0.63%$4.82$4.47405,568 shs$293.40 million06/24/2025$4.64$4.74+2.16%$4.85$4.61462,745 shs$291.56 million06/23/2025$4.63$4.64+0.22%$4.65$4.46467,974 shs$285.41 million Get the Latest News and Ratings for GLUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$4.49$4.63+3.12%$4.66$4.37505,507 shs$284.79 million06/19/2025$4.49$4.49$4.68$4.41373,757 shs$276.18 million06/18/2025$4.57$4.49-1.75%$4.68$4.41373,757 shs$276.18 million06/17/2025$4.82$4.57-5.19%$4.94$4.57367,455 shs$281.10 million06/16/2025$4.91$4.82-1.83%$5.11$4.66551,822 shs$296.48 million06/13/2025$4.92$4.91-0.20%$5.01$4.74380,743 shs$302.01 million06/12/2025$5.05$4.92-2.57%$5.03$4.87413,498 shs$302.63 million06/11/2025$5.08$5.05-0.59%$5.26$5.03531,790 shs$310.63 million06/10/2025$4.92$5.08+3.25%$5.20$4.97278,176 shs$312.47 million06/09/2025$5.01$4.92-1.80%$5.19$4.82269,921 shs$302.63 million06/06/2025$4.62$5.01+8.44%$5.04$4.61454,336 shs$308.17 million06/05/2025$4.61$4.62+0.22%$4.73$4.51507,307 shs$284.18 million06/04/2025$4.64$4.61-0.65%$4.77$4.56229,652 shs$283.56 million Related Companies CVAC Stock Price Chart CALT Stock Price Chart GPCR Stock Price Chart ABCL Stock Price Chart PAHC Stock Price Chart NTLA Stock Price Chart AMPH Stock Price Chart WVE Stock Price Chart DYN Stock Price Chart ARDX Stock Price Chart Receive GLUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLUE) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monte Rosa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monte Rosa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
